Cargando…
DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
BACKGROUND: Screening for prediabetes and asymptomatic diabetes is important for preventing development to an irreversible stage. The current diagnosis of prediabetes and diabetes is based on blood glucose or HbA1c (an invasive method). The aim of this study was to assess the efficacy and safety of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556964/ https://www.ncbi.nlm.nih.gov/pubmed/33054764 http://dx.doi.org/10.1186/s12938-020-00823-x |
_version_ | 1783594319767142400 |
---|---|
author | Zhu, Xiaopeng Tang, Jing Lin, Huandong Chang, Xinxia Xia, Mingfeng Wang, Liu Yan, Hongmei Bian, Hua Gao, Xin |
author_facet | Zhu, Xiaopeng Tang, Jing Lin, Huandong Chang, Xinxia Xia, Mingfeng Wang, Liu Yan, Hongmei Bian, Hua Gao, Xin |
author_sort | Zhu, Xiaopeng |
collection | PubMed |
description | BACKGROUND: Screening for prediabetes and asymptomatic diabetes is important for preventing development to an irreversible stage. The current diagnosis of prediabetes and diabetes is based on blood glucose or HbA1c (an invasive method). The aim of this study was to assess the efficacy and safety of DS21, a new noninvasive technology, for noninvasive screening for prediabetes and diabetes. METHODS: A total of 939 subjects were divided into a normal control group (NC, n = 308), impaired glucose regulation group (IGR, n = 312), and diabetes (DM) group (n = 319). All subjects underwent the DS21 test, and mean hands–feet, hand, and feet conductance values were analyzed. The diagnostic accuracy of the conductance value was analyzed by receiver-operating characteristic (ROC) curve. RESULTS: The conductance values for hands–feet, hands, and feet in the DM and IGR groups were significantly lower than those in the NC group (all P < 0.01). The area under the ROC curve (AUCROC) for distinguishing NC/IGR was highest when using hands–feet conductance values (0.766 [95% confidence interval, CI 0.730, 0.803]). However, the AUCROCs of distinguishing NC/abnormal glucose metabolism (AGM, including IGR+DM), non-diabetes (NDM)/DM, and IGR/DM were highest when using conductance values for hands at 0.782 [95% CI 0.752, 0.812], 0.688 [95% CI 0.653, 0.723] and 0.573 [95% CI 0.528, 0.617], respectively (all P < 0.01). Hand conductance of values 75.0 (sensitivity 0.769, specificity 0.660), 77.1 (sensitivity 0.718, specificity 0.695), 68.4 (sensitivity 0.726, specificity 0.555), and 58.1 (sensitivity 0.384, specificity 0.744) were recommended as the screening thresholds for NC/AGM, NC/IGR, NDM/DM, and IGR/DM, respectively. A hand conductance value 66.0 was also recommended to distinguish NC/AGM due to its high sensitivity and high PPV. No adverse events occurred in the test. CONCLUSIONS: DS21 is fast, noninvasive, low cost, reliable and safe, which makes it a feasible device for screening for prediabetes and diabetes, especially in a large population. |
format | Online Article Text |
id | pubmed-7556964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75569642020-10-15 DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population Zhu, Xiaopeng Tang, Jing Lin, Huandong Chang, Xinxia Xia, Mingfeng Wang, Liu Yan, Hongmei Bian, Hua Gao, Xin Biomed Eng Online Research BACKGROUND: Screening for prediabetes and asymptomatic diabetes is important for preventing development to an irreversible stage. The current diagnosis of prediabetes and diabetes is based on blood glucose or HbA1c (an invasive method). The aim of this study was to assess the efficacy and safety of DS21, a new noninvasive technology, for noninvasive screening for prediabetes and diabetes. METHODS: A total of 939 subjects were divided into a normal control group (NC, n = 308), impaired glucose regulation group (IGR, n = 312), and diabetes (DM) group (n = 319). All subjects underwent the DS21 test, and mean hands–feet, hand, and feet conductance values were analyzed. The diagnostic accuracy of the conductance value was analyzed by receiver-operating characteristic (ROC) curve. RESULTS: The conductance values for hands–feet, hands, and feet in the DM and IGR groups were significantly lower than those in the NC group (all P < 0.01). The area under the ROC curve (AUCROC) for distinguishing NC/IGR was highest when using hands–feet conductance values (0.766 [95% confidence interval, CI 0.730, 0.803]). However, the AUCROCs of distinguishing NC/abnormal glucose metabolism (AGM, including IGR+DM), non-diabetes (NDM)/DM, and IGR/DM were highest when using conductance values for hands at 0.782 [95% CI 0.752, 0.812], 0.688 [95% CI 0.653, 0.723] and 0.573 [95% CI 0.528, 0.617], respectively (all P < 0.01). Hand conductance of values 75.0 (sensitivity 0.769, specificity 0.660), 77.1 (sensitivity 0.718, specificity 0.695), 68.4 (sensitivity 0.726, specificity 0.555), and 58.1 (sensitivity 0.384, specificity 0.744) were recommended as the screening thresholds for NC/AGM, NC/IGR, NDM/DM, and IGR/DM, respectively. A hand conductance value 66.0 was also recommended to distinguish NC/AGM due to its high sensitivity and high PPV. No adverse events occurred in the test. CONCLUSIONS: DS21 is fast, noninvasive, low cost, reliable and safe, which makes it a feasible device for screening for prediabetes and diabetes, especially in a large population. BioMed Central 2020-10-14 /pmc/articles/PMC7556964/ /pubmed/33054764 http://dx.doi.org/10.1186/s12938-020-00823-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhu, Xiaopeng Tang, Jing Lin, Huandong Chang, Xinxia Xia, Mingfeng Wang, Liu Yan, Hongmei Bian, Hua Gao, Xin DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population |
title | DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population |
title_full | DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population |
title_fullStr | DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population |
title_full_unstemmed | DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population |
title_short | DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population |
title_sort | ds21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in chinese population |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556964/ https://www.ncbi.nlm.nih.gov/pubmed/33054764 http://dx.doi.org/10.1186/s12938-020-00823-x |
work_keys_str_mv | AT zhuxiaopeng ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT tangjing ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT linhuandong ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT changxinxia ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT xiamingfeng ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT wangliu ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT yanhongmei ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT bianhua ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation AT gaoxin ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation |